Results 21 to 30 of about 40,271 (232)

Oxytocin exerts harmful cardiac repolarization prolonging effects in drug-induced LQTS

International Journal of Cardiology: Heart & Vasculature, 2022
Background: Oxytocin is used therapeutically in psychiatric patients. Many of these also receive anti-depressant or anti-psychotic drugs causing acquired long-QT-syndrome (LQTS) by blocking HERG/IKr.
Paul Kreifels, Ilona Bodi, Tibor Hornyik, Gerlind Franke, Stefanie Perez-Feliz, R. Lewetag, Robin Moss, Alessandro Castiglione, David Ziupa, Manfred Zehender, Michael Brunner, Christoph Bode, Katja E. Odening   +12 more
doaj   +1 more source

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study

Drug Design, Development and Therapy, 2021
David P Walling,1 Howard A Hassman,2 Lourdes Anta,3 Lourdes Ochoa,4 Ignacio Ayani,3 Javier Martínez,3 Ibon Gutierro4 1Collaborative Neuroscience Network, LLC Garden Grove, Garden Grove, CA, USA; 2Hassman Research Institute, Berlin, NJ, USA; 3Medical ...
Walling DP, Hassman HA, Anta L, Ochoa L, Ayani I, Martínez J, Gutierro I   +6 more
doaj  

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels

Neuropsychopharmacology Reports, 2021
Aim Several reports have shown that risperidone increases prolactin concentrations, while aripiprazole decreases prolactin concentrations. The frequency of abnormal prolactin concentrations in patients with schizophrenia receiving these drugs is still ...
Minami Tasaki, Norio Yasui‐Furukori, Saaya Yokoyama, Masataka Shinozaki, Norio Sugawara, Kazutaka Shimoda   +5 more
doaj   +1 more source

Risperidone-induced maculopapular rashes in a child

Annals of Indian Psychiatry, 2023
We report the case and the literature focusing on dermatological problems as a possible side effect of risperidone. A 10-year-old boy with attention deficit hyperactivity disorder, who was maintaining well on atomoxetine, developed rashes on addition of ...
Enub Ali, Ankur Sachdeva, Shanta Passi
doaj   +1 more source

Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine [PDF]

, 2002
The aim of this investigation was to compare the degree of striatal dopamine-(D2) receptor blockade by two atypical antipsychotic drugs, risperidone and olanzapine.
Tatsch, K., Frodl, T., Preuss, Ulrich W., Rossmüller, B., Möller, H.-J., Preuss, U. W., Meisenzahl, E. M., Schmitt, G. J. E., Dresel, S., Hahn, K.   +9 more
core   +1 more source

Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis

BMC Psychiatry, 2011
Background To compare the efficacy and tolerability of paliperidone extended-release (ER) with risperidone immediate-release using propensity score methodology.
Schooler Nina, Lindenmayer Jean-Pierre, Bossie Cynthia A, Turkoz Ibrahim, Canuso Carla M   +4 more
doaj   +1 more source

Factors influencing blood prolactin levels in patients with schizophrenia under risperidone treatment

Taiwanese Journal of Psychiatry, 2023
Objectives: Risperidone, a dopamine and serotonin antagonist or a second-generation (atypical) antipsychotic drug, is commonly prescribed for various psychiatric disorders, including schizophrenia, bipolar disorder, and autism spectrum disorders.
Mong-Liang Lu, Yi-Hang Chiu, Kah Kheng Goh   +2 more
doaj   +1 more source

Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study

Annals of General Psychiatry, 2009
Background A reporting association of risperidone with pituitary tumors has been observed. Because such tumors are highly prevalent, there may be other reasons why they were revealed in association with risperidone treatment.
Wu Jasmanda, Mahmoud Ramy, Pandina Gahan, Gianfrancesco Frank D, Wang Ruey H   +4 more
doaj   +1 more source

Relapse in patients with schizophrenia: a comparison between risperidone and haloperidol [PDF]

Brazilian Journal of Psychiatry, 2003
OBJECTIVES: To compare rates of rehospitalization and time to relapse in risperidone vs. haloperidol-treated schizophrenic patients discharged from the hospital. METHODS: Randomized controlled trial comparing risperidone and haloperidol regarding relapse
Eduardo Pondé de Sena, Rogério Santos-Jesus, Ângela Miranda-Scippa, Lucas de Castro Quarantini, Irismar Reis de Oliveira   +4 more
doaj   +1 more source

The role of harms and burdens in clinical practice guidelines: Lessons learned from the American Psychological Association's guideline development

Clinical Psychology: Science and Practice, EarlyView., 2020
Abstract Growing evidence supports the efficacy of various psychosocial interventions yet provides very little information about the potential harms and burdens of treatment. Lacking such information makes it difficult to make truly informed decisions about treatment options.
Raquel W. Halfond, Caroline Vaile Wright, Lynn F. Bufka   +2 more
wiley   +1 more source